The relationship between motor cortex excitability and severity of Alzheimer's disease: A transcranial magnetic stimulation study

INTRODUCTION In Alzheimer's disease (AD), transcranial magnetic stimulation (TMS) studies have been limited to test motor cortical excitability. The aim of this study was to investigate the inhibitory circuits of the motor cortex and to relate these to measures of cognitive function in AD patients. Results were compared with those of a control group of healthy subjects matched for age, sex and education. PATIENTS AND METHODS Forty-five AD patients and 37 healthy volunteers were included in the study. Each participant received a neurological evaluation, Mini-Mental State Examination (MMSE), and Clinical Dementia Rating (CDR). Neurophysiological evaluations included resting and active motor threshold (rMT and aMT), motor evoked potential (MEP), cortical silent period (CSP), and transcallosal inhibition (TI). RESULTS AD patients showed significantly reduced rMT, aMT and shorter MEP onset latency; in addition there was a prolongation of both CSP and TI. There was a significant positive correlation between the MMSE and CDR, on the one hand, and aMT and rMT, on the other hand, whereas the correlation was negative with CSP and TI durations. CONCLUSION AD is associated with hyperexcitability of the motor cortex, which supports the hypothesis that changes in GABAb and glutamate function are important factors in cognitive impairment.

[1]  Maria Grazia Marciani,et al.  Effect of Vigabatrin on motor responses to transcranial magnetic stimulation An effective tool to investigate in vivo GABAergic cortical inhibition in humans , 2004, Brain Research.

[2]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[3]  J. Liepert,et al.  Orally administered atropine enhances motor cortex excitability: a transcranial magnetic stimulation study in human subjects , 2001, Neuroscience Letters.

[4]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[5]  B. Christensen,et al.  The mechanisms of interhemispheric inhibition in the human motor cortex , 2002, The Journal of physiology.

[6]  M. Albert,et al.  Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey , 1996, Journal of neuropathology and experimental neurology.

[7]  Raffaele Ferri,et al.  Motor cortex excitability in Alzheimer disease: one year follow-up study , 2002, Neuroscience Letters.

[8]  P. Fitzgerald,et al.  A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation , 2002, Schizophrenia Research.

[9]  R. Duara,et al.  [Cerebral white matter bundle alterations in patients with dementia of Alzheimer type and patients with multi-infarct dementia--magnetic resonance imaging study]. , 1990, Rinsho shinkeigaku = Clinical neurology.

[10]  G Gainotti,et al.  Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[12]  C. Culmsee,et al.  Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases , 1999, Annals of the New York Academy of Sciences.

[13]  G. V. Van Hoesen,et al.  Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone , 1987, Annals of neurology.

[14]  J. Liepert,et al.  Motor cortex disinhibition in Alzheimer's disease , 2001, Clinical Neurophysiology.

[15]  Pedro C. Miranda,et al.  Magnetic stimulation in Alzheimer’s disease , 1997, Journal of Neurology.

[16]  P. Delwaide,et al.  Motor cortex inhibition is not impaired in patients with Alzheimer’s disease: evidence from paired transcranial magnetic stimulation , 1999, Journal of the Neurological Sciences.

[17]  G. Fisher,et al.  Free D-aspartate and D-alanine in normal and Alzheimer brain , 1991, Brain Research Bulletin.

[18]  K. Jellinger,et al.  Morphometry of the corpus callosum in normal aging and Alzheimer's disease. , 1991, Journal of neural transmission. Supplementum.

[19]  A. Berardelli,et al.  Altered response to rTMS in patients with Alzheimer's disease , 2006, Clinical Neurophysiology.

[20]  R. Nardone,et al.  Transcranial magnetic stimulation shows impaired transcallosal inhibition in Marchiafava–Bignami syndrome , 2006, European journal of neurology.

[21]  G. Caruso,et al.  Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer disease , 1996, Journal of the Neurological Sciences.

[22]  Paolo Maria Rossini,et al.  Motor cortex excitability in Alzheimer's disease: A transcranial magnetic stimulation study , 2003, Annals of neurology.

[23]  A. Berardelli,et al.  Changes in the cortical silent period after repetitive magnetic stimulation of cortical motor areas , 2000, Experimental Brain Research.

[24]  N. Sims,et al.  Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives , 1993, Journal of neurochemistry.

[25]  D. Neary,et al.  Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease , 1990, Neuroscience.

[26]  E. Masliah,et al.  Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease , 1996 .

[27]  K. Shoumura,et al.  Structural organization of ‘callosal’ OBg in human corpus callosum agenesis , 1975, Brain Research.

[28]  Raffaele Ferri,et al.  Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity , 2001, Neuroscience Letters.

[29]  Robert Chen,et al.  Short interval intracortical inhibition and facilitation during the silent period in human , 2007, The Journal of physiology.

[30]  S. Rossi,et al.  Clinical neurophysiology of aging brain: From normal aging to neurodegeneration , 2007, Progress in Neurobiology.

[31]  J. Rothwell,et al.  Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation , 2002, Neurology.

[32]  A. Nordberg,et al.  Neuroreceptor changes in Alzheimer disease. , 1992, Cerebrovascular and brain metabolism reviews.

[33]  M J Campbell,et al.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  Robert Chen,et al.  Interactions between two different inhibitory systems in the human motor cortex , 2001, The Journal of physiology.

[35]  G. Wilcock,et al.  The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.

[36]  K J Werhahn,et al.  Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans , 1999, The Journal of physiology.

[37]  F Lepore,et al.  Interhemispheric disconnection syndrome in Alzheimer's disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.